VOOZH about

URL: https://pubmed.ncbi.nlm.nih.gov/32839585/

⇱ Lifting the mask on neurological manifestations of COVID-19 - PubMed


Clipboard, Search History, and several other advanced features are temporarily unavailable.
Skip to main page content
👁 Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

👁 Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Abstract

As the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic spreads, it is becoming increasingly evident that coronavirus disease 2019 (COVID-19) is not limited to the respiratory system, and that other organs can be affected. In particular, virus-related neurological manifestations are being reported more and more frequently in the scientific literature. In this article, we review the literature on the association between COVID-19 and neurological manifestations, present evidence from preclinical research suggesting that SARS-CoV-2 could be responsible for many of these manifestations, and summarize the biological pathways that could underlie each neurological symptom. Understanding the mechanisms that lead to neurological manifestations in patients with COVID-19 and how these manifestations correlate with clinical outcomes will be instrumental in guiding the optimal use of targeted therapeutic strategies.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

👁 Fig. 1
Fig. 1. Possible mechanisms underlying neurological manifestations in patients with SARS-CoV-2 infection.
The neurological diseases that have been observed in individuals with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can be split into three categories on the basis of the presumed underlying mechanism. These mechanisms are pulmonary and systemic disease (orange), direct invasion of the nervous system (yellow) and post-infectious immune-mediated complications (green). ADEM, acute disseminated encephalomyelitis; ANE, acute necrotizing encephalopathy; GBS, Guillain–Barré syndrome.

Comment in

References

    1. World Health Organization. Coronavirus disease 2019 (COVID-19) Situation Report-51. https://www.who.int/docs/default-source/coronaviruse/situation-reports/2... (WHO, 2020).
    1. Zou L, et al. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. N. Engl. J. Med. 2020;382:1177–1179. doi: 10.1056/NEJMc2001737. - DOI - PMC - PubMed
    1. World Health Organization. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). https://www.who.int/publications/i/item/report-of-the-who-china-joint-mi... (WHO, 2020).
    1. Zhang H, Penninger JM, Li Y, Zhong N, Slutsky AS. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med. 2020;46:586–590. doi: 10.1007/s00134-020-05985-9. - DOI - PMC - PubMed
    1. Zubair AS, et al. Neuropathogenesis and neurologic manifestations of the coronaviruses in the age of coronavirus disease 2019: a review. JAMA Neurol. 2020 doi: 10.1001/jamaneurol.2020.2065. - DOI - PMC - PubMed
Cite

NCBI Literature Resources

MeSH PMC Bookshelf Disclaimer

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.